La maladie de Parkinson en France (serveur d'exploration)

Attention, ce site est en cours de développement !
Attention, site généré par des moyens informatiques à partir de corpus bruts.
Les informations ne sont donc pas validées.

Eléments de l'association

Poitou-Charentes98
Guylène Page7
Poitou-Charentes Sauf Guylène Page" 92
Guylène Page Sauf Poitou-Charentes" 1
Poitou-Charentes Et Guylène Page 6
Poitou-Charentes Ou Guylène Page 99
Corpus9014
\n\n\n\n \n

List of bibliographic references

Number of relevant bibliographic references: 6.
Ident.Authors (with country if any)Title
002551 Stéphanie Pain [France] ; Laurence Barrier [France] ; Julie Deguil [France] ; Serge Milin [France] ; Alain Piriou [France] ; Bernard Fauconneau [France] ; Guylène Page [France]A cell-permeable peptide inhibitor TAT-JBD reduces the MPP+-induced caspase-9 activation but does not prevent the dopaminergic degeneration in substantia nigra of rats
002685 Julie Deguil [France] ; David Jailloux [France] ; Guylène Page [France] ; Bernard Fauconneau [France] ; Jean-Luc Houeto [France] ; Michel Philippe [France] ; Jean-Marc Muller [France] ; Stéphanie Pain [France]Neuroprotective effects of pituitary adenylate cyclase–activating polypeptide (PACAP) in MPP+‐induced alteration of translational control in Neuro‐2a neuroblastoma cells
003477 Stéphanie Barc [France] ; Guylène Page [France] ; Laurence Barrier [France] ; Lucette Garreau [France] ; Denis Guilloteau [France] ; Bernard Fauconneau [France] ; Sylvie Chalon [France]Relevance of different striatal markers in assessment of the MPP+-induced dopaminergic nigrostriatal injury in rat
003481 Stéphanie Barc [France] ; Guylène Page [France] ; Laurence Barrier [France] ; Francois Huguet [France] ; Bernard Fauconneau [France]Progressive alteration of neuronal dopamine transporter activity in a rat injured by an intranigral injection of MPP+
003827 Stéphanie Barc [France] ; Guylène Page [France] ; Laurence Barrier [France] ; Alain Piriou [France] ; Bernard Fauconneau [France]Impairment of the neuronal dopamine transporter activity in MPP+-treated rat was not prevented by treatments with nitric oxide synthase or poly(ADP-ribose) polymerase inhibitors
003849 Stéphanie Barc [France] ; Guylène Page [France] ; Bernard Fauconneau [France] ; Laurence Barrier [France] ; Francois Huguet [France]A new in vitro approach for investigating the MPTP effect on DA uptake

Wicri

This area was generated with Dilib version V0.6.29.
Data generation: Wed May 17 19:46:39 2017. Site generation: Mon Mar 4 15:48:15 2024